Medical oncologist Dr. Konstantinos Leventakos of Mayo Clinic Comprehensive Cancer Center discusses the benefits of
using NGS with CGP during ongoing lung cancer treatment. He discusses how having genetic testing throughout the course of your cancer treatment can be important since cancer that has been treated
can become resistant over time. He explains that biomarker testing can help doctors
detect pathways of resistance and allow them to better identify new treatments for you. As genetic testing technology advances, Dr. Leventakos says that this may also lead to new biomarkers to be found which can be helpful for offering additional paths of treatment.
-
Share with family and friends:
Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about lung cancer which will help other patients, caregivers and families.